Akero Therapeutics shares plunge on liver disease treatment’s mixed results By: MarketWatch October 10, 2023 at 08:10 AM EDT Company's lead product candidate shows some benefit for patients with cirrhosis due to fatty liver disease Read More >> Related Stocks: Akero Therapeutics Inc
